Brief: Neuroscientific Biopharmaceuticals Seeks Trading Halt
Aug 19 (Reuters) - NeuroScientific Biopharmaceuticals Ltd
NSB.AX :
* TRADING HALT-NSB.AX
* SEEKS TRADING HALT TO FINALISE FURTHER INFORMATION ON
RESULTS
FROM PULMONARY STUDIES ANNOUNCED ON 19 AUG
Source text for Eikon: ID:nASXbmKSxs
Further company coverage: NSB.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Neuroscientific Biopharmaceuticals
See all newsBrief: Neuroscientific Biopharmaceuticals Appoints Chris Knee As CFO
Brief: Neuroscientific Biopharmaceuticals Seeks Trading Halt
Australia's NeuroScientific Biopharmaceuticals surges on positive clinical results
Brief: Neuroscientific Biopharmaceuticals Requests Trading Halt
Brief: Neuroscientific Biopharmaceuticals Appoints Nathan Smith As CEO